GLOBAL HEALTH BRAND
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 43%
While the indices might be witnessing correction on intra intra-basis, the broader markets are still very much under the control of the bulls. There is greater likelihood of bullish sentiment continuing, so be bullish but more than anything else in the long term what matters for a stock is earnings and valuation. So be selective, avoid impulsive investing, and keep reviewing one’s portfolio and stay away from penny stocks especially. It is very likely that some of the penny stocks will fly and be distributed amongst retail investors. We look at stocks which have witnessed a continuous rise in their score in the last one month. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Lupin, Eugia recall products from US market: USFDA
Drugmakers Lupin and Aurobindo Pharma are recalling products from the American market due to manufacturing issues, as reported by the US Food and Drug Administration (USFDA). Lupin Pharmaceuticals Inc, a US-based unit of Lupin, is specifically recalling 3,552 bottles of Cefixime for Oral Suspension (USP 200 mg/5 mL) because of "failed content uniformity specifications."
Beauty secrets: Inside India's booming beauty industry that relies on hundreds of contract manufacturers
Nishit Dedhia, the MD and cofounder of Kain Cosmeceuticals, is leading a tour of his cosmetics manufacturing facility in Khopoli, Maharashtra. The facility produces a variety of beauty products for the growing direct-to-consumer market in India.
Impact of GCC boom; Infosys staffers cling to WFH in FY24
Happy Thursday! The explosive growth in India's global capability centres (GCC) has benefited the real estate, staffing, and infra sectors. This and more in today’s ETtech Morning Dispatch.
- Go To Page 1
Zepto’s mega financing; shareholder battle at Kenko Health
Happy Wednesday! Zepto is holding talks with investment fund DST Global and venture capital firm Lightspeed for funding. Details on this and more in today's ETtech Morning Dispatch.
Boat's parent brand Imagine Marketing India in talks with investors to raise funds
Imagine Marketing's IPO plans were shelved in 2022. CEO Sameer Mehta said the company has no pressing need of capital and hence is not doing any roadshows to raise funds. “However, there are some inbound interests from a large global fund, sovereign fund and one strategic investor. It’s still early days and we are not desperate,” he said.
Surprise poll results impact startups' plans, and other top stories this week
In a week charged with political buzz, the BJP government came back to power after a stormy election, but without a full majority that left it dependent on the whims of its alliance partners. Unnerved, the markets went into a tailspin on counting day, with both benchmark indices, Sensex and Nifty50, dropping 8% intraday. They recovered a day later as hopes of a stable government revived.
Adopting global standard, infra, risk-based regulation to help India improve quality of goods for exports: GTRI
The GTRI also recommended support to SMEs, avoiding quality control orders becoming non-tariff barriers, regulatory impact assessment, developing globally acceptable standards and inking mutual recognition pacts with trading partners to strengthen India's quality systems.
Over 40 pc ads in Cricket World Cup 2023 promoted smokeless tobacco brands: Study
According to the study conducted by a group of experts from the Indian Council of Medical Research (ICMR) and Vital Strategies, of the total 41.3 per cent surrogate advertisements of smokeless tobacco (SLT) brands, 39.9 per cent were telecast during India's matches and 37.8 per cent during matches featuring one or both teams from South Asia (Afghanistan, Bangladesh, Pakistan and Sri Lanka).
World Bicycle Day Sale - Cycle your way into fitness with Amazon Sale 2024
Mark World Bicycle Day with the Amazon Sale 2024, featuring incredible discounts on bicycles and cycling accessories. Whether you're a casual rider or a serious cyclist, this sale has everything you need to enhance your biking experience. From mountain bikes and road bikes to helmets, lights, and bike locks, find top-quality gear at unbeatable prices. Get ready to pedal your way to better health and fitness with these amazing offers!
New-age consumer brands trend on deal street
Uppercase–a luggage brand started by former VIP Industries MD Sudip Ghose–is in talks with Flipkart-backer Accel to raise new capital, sources told us. This would be the 3rd major deal in the space after Peak XV Partners’ Mokobara investment and Lighthouse’s bet on Safari.
Beware! Misleading ad-game tricking Indians rather than offering ‘Umeedo Wali Dhoop’?
Advertisements have left a lasting impact over the years, from Amul's iconic "Utterly Butterly Delicious" to Cadbury's memorable ads. However, misleading claims in ads, especially in the digital space, are increasing. ASCI found that 81% of the 8,299 ads evaluated in 2023-24 were misleading. Social media influencers often promote products without proper regulation. Technological advancements and ethical guidelines are needed to ensure transparency and authenticity in advertising, to maintain consumer trust and loyalty.
A little bit of ‘utopia’: How this company wants to make a dent in health beverage market
The Indian health beverage market is currently valued at $10 billion and expected to hit $30 billion by 2026. Utopian Drinks is eyeing a piece of this pie.
Stocks with tailwinds called advantage India: 5 largecap stocks from 3 different sectors with an upside potential of upto 36 %
In terms of valuations and sentiment we are not far from the place where we were in the last quarter of 2023 or early part of this year. When it was not possible to find stocks which can be called as “fairly valued” forget “undervalued”, and the sentiment was very bullish. The only difference between then and now is that we have election results which are coming up. Surely a confirmation on 4th June that continuity in the policy making is a big factor. But there is another thing which long term investors need to look at before investing. Whether the company or the sector has an advantage due to India as a country. A well known example, which has been present for decades is that of the IT industry. India as a country is a factory of software engineers, and that is our strength. So when investing for the long term, look at sectors where we have some strong tailwinds due to our human capital.
Tea brand Freshleaf raises Rs 1 cr in seed round led by Inflection Point Ventures
Vikram Ramasubramanian, Partner, Inflection Point Ventures says, “Freshleaf’s approach to crafting premium teas combined with health benefits presents an exciting opportunity for us to contribute to a startup that is set to redefine the tea industry. We believe in Freshleaf’s dedication to fostering a culture of health, wellness and taste.”
Responsible Innovation, how a blueprint for collaborative action is advancing global healthcare
On the occasion of the Abu Dhabi Global Healthcare Week (ADGHW), Dr. Asma Ibrahim Al Mannaei, Executive Director of the Research and Innovation Centre, discusses the UAE's prioritisation of healthcare in driving investments and partnerships focusing on advancing technology and attracting top talent and fostering collaboration with India reflecting shared challenges and opportunities in healthcare. Overall, collaboration with global partners and investment in manufacturing capabilities exemplify the UAE's commitment to healthcare excellence and innovation, while initiatives like Malaffi enhance data-driven services. Read on to discover how ADGHW aims to faciliate responsible innovation in healthcare, even as the UAE emphasises patient rights protection in an era of advancing AI and data usage.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Defensive stocks: FMCG is “passe”; 8 stocks from two sectors may be called “new defensives” with upside potential of up to 32%
1994 to 2024 is a difference of 30 years, but there is one thing which has remained constant, advice to move to defensive stocks when markets are volatile or there is an event risk. Four questions need to be asked; first, what is a defensive stock? Second, is a stock which was considered a defensive in 1994 when the Indian economy was just opening, still a defensive stock in 2024 ? Third, should there be a new definition of defensive stock in 2024 ? Last but not the least, what are the new defensive sectors or stocks?
Empowering healthcare innovations: Dr. Noura Khamis Al Ghaithi on ADGHW's role in global healthcare collaboration
H.E. Dr. Noura Khamis Al Ghaithi discusses ADGHW as a platform for global healthcare collaboration, focusing on innovations and partnerships with Indian healthcare providers. The event aims to develop precision health initiatives, strengthen life sciences research, attract medical tourism, and support a growing startup ecosystem.
Before global scrutiny, Indian spice maker MDH faced many US rejections
Hong Kong suspended sales last month of three spice blends made by MDH and one by another Indian company, Everest, for apparently containing high levels of a cancer-causing pesticide. Ethylene oxide is unfit for human consumption and a cancer risk with long exposure. India is the world's biggest spice producer and is also the largest consumer and exporter of spices.
Will short-term headwinds impact long-term potential? 6 stocks from hospital sector with upside potential of up to 30%
After outperforming the market, stocks from the healthcare sector or what is more commonly called hospital sector have gone into consolidation mode. The consolidation has been prompted by the fact that voices have been raised about differential pricing in the services of the hospitals. The matter has reached the Supreme Court and will be heard. Given the fact that while medicine is a science but in real life as practice it has an element of art in it. For example, a hospital who has a renowned surgeon from any branch, be it cardio, neuro on its roll may charge up more for the same surgery as compared to others. While the moral debate is on one side, there is another side to the story. In a country like India, the healthcare infrastructure needs vast expansion and upgradation. To some extent the street is ruthless and does not have much moral obligation.
Yoga pants inventor Lululemon Athletica plans to enter India
Lululemon Athletica plans to enter India independently, focusing on locations in Mumbai, Delhi, and Bangalore. The company, known for yoga pants, aims to tap into the country's growing demand for fitness and athleisure wear.
Glenmark recalls 6,528 bottles of blood pressure drug in US
As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
GPT Healthcare IPO opens for subscription. Should you apply?
GPT Healthcare IPO: GPT Healthcare's IPO, valued at Rs 525 crore, opened for subscription. The company raised Rs 157 crore from anchor investors. Analysts advise subscribing for fair valuations, comprehensive services, and quality medical practices. The price band is Rs 177-186 per share.
Kolkata-based GPT Healthcare announces IPO dates. Check details
The IPO, with a face value of Rs 10, consists of a fresh issue of equity shares, aggregating to Rs 40 crore, and an offer for sale (OFS) of up to 2.6 crore equity shares by BanyanTree Growth Capital II, LLC, a Mauritius-based structured private equity.
RJ Corp buys Global Health shares for Rs 379 crore
The shares were sold by Dunearn Investments Mauritius, which held a 16.02% stake as of December 31, 2023. Jaipuria is the promoter of Devyani International, which operates brands such as KFC, Pizza Hut, and Costa, among others
Medanta shares jump 14%, hit fresh 52-week high on strong Q3 show
The rally has been more pronounced since the company announced its December quarter earnings on Thursday where reported a consolidated PAT of Rs 123.50 crore which was up by 53% YoY. PAT margins increased from 11.4% in Q3 FY23 to 14.5% in Q3 FY24, the company filing said.
Load More
